Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Bioventus Inc. roe for the quarter ending 2026-06-27 was 26.93%, a change of 27.24% year-over-year.
Bioventus Inc. roe for the quarter ending 2026-03-28 was 18.29%, a change of 47.98% year-over-year.
Bioventus Inc. roe for the quarter ending 2025-12-31 was 14.81%, a change of 46.62% year-over-year.
Bioventus Inc. roe for the quarter ending 2025-09-27 was 5.63%, a change of 42.01% year-over-year.
Bioventus Inc. roe for fiscal 2025 was 12.35%, a change of 36.77% from fiscal 2024.
Bioventus Inc. roe for fiscal 2024 was -24.42%, a change of 65.58% from fiscal 2023.
Bioventus Inc. roe for fiscal 2023 was -90.00%, a change of -41.20% from fiscal 2022.
Bioventus Inc. roe for fiscal 2022 was -48.80%, a 1255.81% decline from fiscal 2021.